Omega Healthcare Investors Inc. (OHI) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026
Summary
Omega Healthcare Investors’s revenue went from $901M in fiscal 2016 to $1.2B in fiscal 2025, growth of about 3.1% a year.
Net income in fiscal 2025 was $590M, a net margin of 49.6%; the highest of the period.
Over the twelve months to September 30, 2026, revenue was $1.3B and net income $746M.
Free cash flow was $798M in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count rose 51% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.2B | $1.1B | $950M | $878M | $1.1B | $892M | $929M | $882M | $908M | $901M |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | $796M | — | — | — | — | — | — | $552M | $498M | $315M | $560M |
| Net income | $746M | $590M | $406M | $242M | $427M | $417M | $159M | $341M | $282M | $100M | $366M |
| EPS (diluted) | $2.48 | $1.94 | $1.55 | $1.00 | $1.80 | $1.75 | $0.70 | $1.58 | $1.40 | $0.51 | $1.90 |
| R&D | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth | — | +13.2% | +10.7% | +8.1% | −17.4% | +19.1% | −3.9% | +5.3% | −2.9% | +0.8% | +21.1% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $855M | $879M | $749M | $618M | $626M | $722M | $708M | $554M | $499M | $578M | $625M |
| Capital spending | -$78M | -$81M | -$38M | -$38M | -$47M | -$45M | -$31M | -$53M | -$30M | -$38M | -$40M |
| Free cash flow | $777M | $798M | $712M | $580M | $579M | $677M | $677M | $501M | $470M | $540M | $584M |
| Dividends paid | $804M | $780M | $685M | $644M | $633M | $638M | $612M | $564M | $529M | $503M | $453M |
| Buybacks | — | — | — | — | $142M | — | — | — | — | — | — |
| Stock-based pay | $68M | $44M | $37M | $35M | $27M | $21M | $19M | $15M | $16M | $15M | $14M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $27M | $518M | $443M | $297M | $21M | $164M | $24M | $10M | $86M | $94M |
| Debt | — | $4.3B | $4.9B | $5.1B | $5.3B | $5.3B | $5.2B | $5.2B | $4.5B | $4.6B | $4.4B |
| Equity | — | $5.2B | $4.5B | $3.6B | $3.6B | $3.9B | $3.8B | $4.1B | $3.4B | $3.6B | $3.9B |
| Total assets | — | $10.0B | $9.9B | $9.1B | $9.4B | $9.6B | $9.5B | $9.8B | $8.6B | $8.8B | $8.9B |
| Shares (diluted) | 321M | 305M | 270M | 250M | 244M | 244M | 235M | 222M | 210M | 207M | 202M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — | — | — | — |
| Operating margin | 60.7% | — | — | — | — | — | — | 59.4% | 56.4% | 34.7% | 62.2% |
| Net margin | 56.9% | 49.6% | 38.6% | 25.5% | 48.6% | 39.2% | 17.8% | 36.7% | 31.9% | 11.1% | 40.7% |
| FCF margin | 59.3% | 67.0% | 67.7% | 61.0% | 65.9% | 63.7% | 75.9% | 53.9% | 53.3% | 59.5% | 64.9% |
| ROIC | — | — | — | — | — | — | — | 5.9% | 6.2% | 3.8% | 6.8% |
| ROE | — | 11.4% | 9.0% | 6.8% | 11.8% | 10.7% | 4.2% | 8.2% | 8.2% | 2.8% | 9.5% |
Frequently asked questions
What is Omega Healthcare Investors’s annual revenue?
$1.2B in fiscal 2025 and $1.3B over the twelve months to September 30, 2026.
How much profit does Omega Healthcare Investors make?
Net income was $590M in fiscal 2025 (net margin 49.6%).
Is Omega Healthcare Investors’s revenue growing?
Yes: revenue rose 13.2% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.